BackSummit Therapeutics Overview
Summit Therapeutics Inc

Summit Therapeutics Target Price

Analysts' 12-month price predictions for SMMT.

Get informed when a big investor buys or sells

+ Follow

Share Price

$15.07

Average Target Price

$23.0052.6% upside

3 analysts in the last 4 months

High: $30 | Low: $16

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-04H.C. Wainwright$2352.6% upsideOpen
2026-05-01Piper Sandler$166.2% upsideOpen
2026-02-24H.C. Wainwright$3099.1% upsideOpen
2026-01-14Piper Sandler$40165.4% upsideOpen
2025-12-17Summit Redstone PartnersEtzer Darout$1819.4% upsideOpen
2025-10-21H.C. Wainwright$40165.4% upsideOpen
2025-10-21Barclays$166.2% upsideOpen
2025-09-16Summit Redstone Partners$1313.7% downsideOpen
2025-08-19Summit Redstone PartnersKelsey Goodwin$2139.3% upsideOpen
2025-04-28H.C. Wainwright$44192% upsideOpen
2025-04-25Wells Fargo$3099.1% upsideOpen
2025-04-25JefferiesKelly Shi$44192% upsideOpen
2025-03-26Summit Redstone PartnersYigal Nochomovitz$35132.2% upsideOpen
2025-02-28Summit Redstone Partners$42178.7% upsideOpen
2024-11-04JMP SecuritiesReni Benjamin$32112.3% upsideOpen
2024-09-27Summit Redstone PartnersYigal Nochomovitz$2352.6% upsideOpen
2024-09-25Stifel NicolausBrad Canino$40165.4% upsideOpen
2024-09-16H.C. WainwrightMitchell Kapoor$45198.6% upsideOpen
2024-06-03Stifel NicolausBrad Canino$147.1% downsideOpen
2024-03-25Stifel NicolausBrad Canino$846.9% downsideOpen